Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
16.69
-0.42 (-2.45%)
Jan 14, 2025, 4:00 PM EST - Market closed

Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $294.00 million as of January 14, 2025. Its market cap has increased by 14.71% in one year.

Market Cap
294.00M
Enterprise Value
333.09M
1-Year Change
14.71%
Ranking
Category
Stock Price
$16.69

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $294.00M, an increase of 15.34%. That is a compound annual growth rate of 0.59%.

History

DateMarket Cap% Change
Jan 13, 2025301.40M1.72%
Dec 31, 2024296.30M17.21%
Dec 29, 2023252.80M-2.51%
Dec 30, 2022259.30M-42.78%
Dec 31, 2021453.20M-23.37%
Dec 31, 2020591.40M64.87%
Dec 31, 2019358.70M-6.42%
Dec 31, 2018383.30M-32.57%
Dec 29, 2017568.40M141.36%
Dec 30, 2016235.50M-12.19%
Dec 31, 2015268.20M34.57%
Dec 31, 2014199.30M-20.02%
Dec 31, 2013249.20M-55.93%
Dec 31, 2012565.50M0.60%
Dec 30, 2011562.10M43.14%
Dec 31, 2010392.70M-20.31%
Dec 31, 2009492.80M68.36%
Dec 31, 2008292.70M-62.86%
Dec 31, 2007788.20M164.67%
Dec 29, 2006297.80M47.43%
Dec 30, 2005202.00M-57.71%
Dec 31, 2004477.70M68.26%
Dec 31, 2003283.90M465.54%
Dec 31, 200250.20M-71.28%
Dec 31, 2001174.80M-51.24%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 723.16B
UnitedHealth Group 501.24B
Novo Nordisk 385.14B
Johnson & Johnson 347.71B
AbbVie 313.21B
Merck & Co. 255.20B
Thermo Fisher Scientific 213.57B
AstraZeneca 207.72B
Market Cap Rankings